Ready-to-Drink Beverage Market Projected to Hit USD 430.30 Billion by 2034

Ready-to-Drink Beverage Market

The ready-to-drink beverage (RTDs) market value is expected to rise from USD 206.25 billion in 2024 to USD 430.30 billion by 2034. This market is analyzed to propel ahead at a CAGR of 7.60% over the next decade.

Industry players are driving growth by expanding their presence on college campuses through nutrition-focused initiatives. Additionally, they are collaborating with collegiate sports programs and NIL (Name, Image, and Likeness) athletes to enhance brand visibility and foster product affinity.

As urban consumers face increasingly busy lifestyles, ready-to-drink (RTD) beverage brands are positioning themselves as lifestyle-centric, aligning their offerings with values like freedom, wellness, and authenticity to appeal to modern consumers.

Leading energy RTD brands, such as the U.S.-based Celsius, are cultivating a loyal customer base, particularly within the fitness community. These customers are drawn to the brands’ commitment to authenticity and alignment with active, health-focused lifestyles, reinforcing their connection to the fit lifestyle culture.

Energy RTD beverages make for a great gym partner, study partner, and get-through-your-shift partner as they quench thirst and give an instant surge of energy. Another noted driver for the energy drinks category under the RTD industry is that functional drinks can be paired with meals and food as they taste appetizing, that too without containing sugar content.

The alcoholic ready-to-drink beverage is also gaining momentum in developed and developing countries alike. Their sales are supported by increasing tourism activities and the expanding trend of celebrating everyday moments, packed in a convenient and portable bottle. The growth of alcoholic RTDs in developing countries is a testament to shifting consumer preferences.

“Key players are expanding their presence the world over, by gradually expanding their operations and searching for opportunities and demand outside their homeland. Additionally, players who are agile in responding to the latest consumer preferences and trends are expected to have an advantage over their peers,” says Nandini Roy Choudhury, Client Partner at Future Market Insights.

Key Takeaways from the Ready-to-drink Beverage Market Report

  • The ready-to-drink beverage market share was US$ 150.92 billion in 2019. From 2019 to 2023, the market registered a CAGR of 7.10%.
  • By product type, the coffee segment is predicted to occupy a value share of 21.5% in 2024.
  • Based on nature, the conventional segment is expected to exercise dominance in the global market, obtaining an 86.5% share in the market.
  • Regionally, the consumption patterns indicate that demand for ready-to-drink beverages is expected to be higher in emerging countries than in developed markets.

Latest Developments in the Global Ready-to-drink Beverage Market

  • In November 2023, Kirin Hyoketsu, Japan’s best-selling RTD, made its way to New Zealand. The beverage brand made its Kiwi debut with signature Lemon flavour which is a blend of soda, vodka, and frozen natural lemon juice.
  • In October 2022, Radico Khaitan introduced ready-to-drink options for the vodka brand. In the years to follow, the company shared that it was going to produce three variants, including cola, cosmopolitan, and mojito. At present, the products are sold in Karnataka, followed by Maharashtra, Goa, and Daman & Diu.
  • In December 2023, Coca-Cola India announced the testing of Lemon-Dou in India, which is a ready-to-drink alcoholic beverage.

Enlisted Below are Some Top Market Players

  • Diageo plc
  • Brown-Forman
  • Bacardi Limited
  • Asahi Group Holdings, Ltd.
  • Pernod Ricard
  • Halewood Wines & Spirits
  • SHANGHAI BACCHUS LIQUOR CO., LTD.
  • Suntory Holdings Limited
  • Manchester Drinks Company Ltd.
  • Anheuser-Busch InBev
  • Others

Download the full report for in-depth insights. https://www.futuremarketinsights.com/reports/ready-to-drink-beverages-market

Market Segmentation of Ready-to-drink Beverage Products

By Product Type:

  • Tea
  • Coffee
  • Energy Drinks
  • Yogurt Drinks
  • Dairy-based beverages
  • Non-Dairy Based Beverages
  • Fortified Water
  • Others

By Nature:

  • Organic
  • Conventional

By Packaging:

  • Bottle
  • Tetra Pack
  • Sachet
  • Tin Can
  • Others

By Distribution Channel:

  • Supermarkets/Hypermarkets
  • Convenience Stores
  • Grocery Stores
  • Speciality Stores
  • Online retail

Different Regional Markets are as Follows:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Dextrose Monohydrate Market Driven by Innovations, Forecasted 4.0% CAGR by 2033

Dextrose Monohydrate Market

The global dextrose monohydrate market is projected to reach a value of USD 498 million by 2023 and is expected to evolve at a CAGR of 4.0% to reach USD 708.7 million by 2033.

The demand for dextrose monohydrate is projected to rise significantly during the forecast period, driven by its numerous health benefits. Its versatile applications as a sweetener, binder, emulsifier, and thickener are expected to further its adoption in the food and beverage industry.

The increasing preference for nutritious foods and the growing demand for convenience meals are key factors fueling this growth. Additionally, expanded production of antacid suspensions in the pharmaceutical industry, rising demand in the personal care sector, and the continuous shift toward low-calorie food products are anticipated to propel the global dextrose monohydrate market forward.

Dextrose Monohydrate: Enhancing Shelf Life & Flavor of Processed Meat

Consumers are looking for high-quality, convenient meat products, which is boosting the processed meat market. Dextrose monohydrate is essential in the enhancement of processed meat. It improves color development, salt penetration, flavor, and pH balance during injection and immersion curing. Meat-based breakfast options such as bacon are gaining popularity over pancakes due to changing preferences and a need for protein-rich meal options.

A carbohydrate blend, containing dextrose monohydrate, ensures proper fermentation, controlled pH, and the necessary microbial population in fermented dry sausages. As a result, the sausages have exceptional sensory qualities, body, and flavor. The adoption of dextrose monohydrate in processed beef increases market sales by satisfying customer tastes and extending shelf life.

Sugary Suppression: Artificial Sweeteners Curb Dextrose Monohydrate’s Growth

Excessive dextrose consumption has been linked to obesity, liver function disruption, and increased uric acid levels. Regulations limiting the usage of dextrose monohydrate hinder its demand growth. In search of low-calorie alternatives, manufacturers are turning to artificial sweeteners that help maintain blood sugar levels. Their widespread use in processed foods boosts their sales, driven by their ability to retain taste.

FDA-approved sweeteners such as saccharin, sodium benzoate, and aspartame have gained popularity in the food industry. Aspartame, being much sweeter than sugar, reduces production costs. The increasing utilization of artificial sweeteners is expected to hamper dextrose monohydrate market growth.

North America Leads Global Dextrose Monohydrate Market

North America is projected to dominate the global dextrose monohydrate industry due to its strong regional segmentation. The region benefits from a high level of awareness and understanding of the product, which contributes to market growth. The increased emphasis on wellness and health among Americans fuels the market expansion of dextrose monohydrate in North America.

Key Takeaways

  • The United States might increase its market share by 21/7% between 2023 and 2033.
  • Between 2023 and 2033, Germany may hold 4.1% of the dextrose monohydrate
  • From 2023 to 2033, the United Kingdom dextrose monohydrate industry registered at a 5% CAGR.
  • Australia to hold a 2.9% share of the dextrose monohydrate market from 2023 to 2033.
  • During the forecast period, the Chinese dextrose monohydrate business to expand at a CAGR of 4.2%.
  • Japan’s share of the dextrose monohydrate industry could reach 2.3% between 2023 and 2033.
  • Through 2033, the Indian dextrose monohydrate market to record a CAGR of 5.3%.
  • The grade segment to hold a market share of 74.5% in the food grade category between 2023 and 2033.
  • Bakery & Confectionary sector to grab a significant market share of 53.6% in the application category between 2023 and 2033.

Competitive Landscape

Major dextrose monohydrate players spend a lot of money on research and development to broaden their product offerings, which may escalate the dextrose monohydrate business to continue expanding.

The dextrose monohydrate players are launching new products, making agreements, purchasing firms, raising capital, and collaborating with other organizations to boost their investments and build a larger global presence. To grow and survive in a more cutthroat and competitive market climate, dextrose monohydrate competitors must provide affordable products.

Download the full report for in-depth insights. https://www.futuremarketinsights.com/reports/dextrose-monohydrate-market

New Developments

  • Tate and Lyle PLC expanded its presence in Asia by inaugurating a cutting-edge application lab in Singapore in 2019. Equipped with advanced technology and pilot-scale capabilities, the lab facilitated collaboration with food and beverage partners to develop delicious products that catered to the preferences of consumers in Asian countries, spanning beverage, dairy, bakery, sauce, and dressing processing.
  • Atlantic Chemicals Trading GmbH established a new warehouse in Stelle, near Hamburg, ensuring efficient delivery of their products. The strategic location of the warehouse enabled the company to procure raw materials promptly and meet customer demands effectively.
  • In 2020, Roquette Frères S.A. launched a digital marketplace, revolutionizing the ordering process for its customers. This user-friendly platform offered convenience, innovation, and ease of use, allowing customers to effortlessly select and order the right products to suit their requirements.

Key Segments

By Grade

  • Food Grade
  • Medical Grade

By Application

  • Bakery & Confectionery
  • Convenience Food
  • Dairy Foods
  • Beverages

By Region

  • North America
  • Latin America
  • Europe
  • Middle East and Africa
  • East Asia
  • South Asia
  • Oceania

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Insect Feed Market Anticipates 17.9% CAGR Growth by 2033, Reports FMI

Insect Feed Market

The global insect feed market is poised for significant growth, with an estimated worth of approximately USD 1,561 million in 2023. This burgeoning sector is anticipated to expand at an impressive annual growth rate of 17.9% from 2023 to 2033. By the end of this period, the market’s value could soar to an estimated USD 8,124 million, driven by increasing demand for sustainable protein sources in agriculture and aquaculture. As the industry evolves, innovations in insect farming and feed formulations are likely to play a crucial role in meeting this rising demand.

As many animals ingest the insects naturally, it makes sense to think about using insect proteins as a potential source of commercial feed additionally, because insects include bioactive components, they are increasingly being used as innovative feed additions to promote the gut health of pet animals.

Sales of animal feed additives are also expected to be constrained by the strict laws and regulations related to introducing new insect feed. For example, the Bovine Spongiform Encephalopathy problem poses a crucial threat to consumer health and safety, impacting the overall approach of using insects as feed in Europe. Another main roadblock to adopting insects as feed in many places is the lack of clear laws and standards governing their usage as food.

Historical Growth and Market Valuation of Insect Feed
Between 2018 and 2022, the insect feed market experienced a robust year-on-year growth rate of approximately 16%. By the close of 2022, the market’s total valuation reached around USD 1,319 million.

Aquaculture Industry Driving Global Demand
The aquaculture sector, constantly seeking cost-effective alternatives to traditional aquafeed like fishmeal, is a key driver of insect feed demand. As the aquaculture industry is projected to grow significantly over the forecast period, the global adoption of insect-based feed products is expected to rise.

U.S. Market: A Hub for Insect Feed Production
In the United States, insect feed production is propelled by the increasing insect farming activities in regions such as Hawaii and their expanded utilization in feed formulations. The U.S. market is set to thrive further, supported by leading manufacturers like JR Unique Foods, Nutritio Technologies, and Endofood.

“Prominent industries producing animal feed have started investing in research to produce cutting-edge insect feed products to expand consumer base in the international market. Besides, some insect feed suppliers are working with other producers to include their goods in preparation of the final product for livestock.” – Nandini Roy Choudhury (Client Partner for Food & Beverages at Future Market Insights, Inc.).

Download the full report for in-depth insights. https://www.futuremarketinsights.com/reports/insect-feed-market

Key Takeaways from the Global Insect Feed Market Study Report by FMI

  • The United States captured most of the global market and is predicted to contribute US$ 491.7 million in 2023.
  • Germany is the leading supplier of insect feeds in Europe and it may contribute to nearly 5.8% of the global market share in 2023.
  • Insect feed demand is rising in China and South Korea, which is expected to lead to strong growth in the Asia Pacific. In 2023, the two countries are estimated to contribute nearly 15.8% and 2.8% of the global revenue share respectively.
  • Australia is another emerging market for insect feeds in the Asia Pacific with an estimated global market share of 1.9% in 2023.
  • With an overall market share of nearly 43% in 2023, the aquaculture segment is expected to lead the market among end users.

Regional Market Comparison

Global Market Share in Percentage

United States Insect Feed Market Share

31.5 %

Germany Insect Feed Market

5.8 %

Japan Insect Feed Market

2.8 %

Australia Insect Feed Market

1.9 %

China Insect Feed Market

15.8 %

Competitive Landscape

To increase their product offerings and introduce cutting-edge items, leading insect feed manufacturers spend highly on research and development. For instance, Nutrition Technologies Company declared in June 2022 to create bacteriophages to replace antibiotics in the protein found in black army flies.

Recent Developments

Protenga Incorporate obtained nearly US$ 1.6 million in July 2020 with Roslin Technologies, a British agri-tech startup. The investment has been made to discover the black soldier fly’s new, effective genetic strains for use in aquaculture, livestock, and pet feed.

Nutrition Technologies and Evonik partnered in March 2022 to do research and development on poultry insect feed. The partnership concentrated on the amino acid needs of Southeast Asian BSF to achieve sustainable results in livestock production by optimizing BSF diets.

In May 2022, Pet World Nutrition Technologies, SPCA Selangor, and Nutrition Technologies introduced a sustainable commercial dog food containing protein from black soldier fly larvae.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Brewer Yeast Powder Market Surges with Vegan Trends, 6.7% CAGR Expected by 2033

Brewer Yeast Powder Market The global brewer yeast powder market is poised to attain a valuation of USD 2,392 million in 2023, propelled by the burgeoning interest and insights into brewer yeast powder.

This trend is expected to pave the way for fresh market opportunities, charting a projected CAGR of 6.7% from 2023 to 2033. By 2033, the market is anticipated to soar to an estimated total valuation of USD 4,554 million.

Brewer’s yeast powder is emerging as a key ingredient in the food industry, offering a dried, powdered form of nutrient-rich yeast. Packed with protein, dietary fiber, vitamin B12, iron, magnesium, and selenium, it delivers a significant nutritional boost. With its nutty flavor, this versatile powder can be blended into smoothies, yogurt, or cereal and incorporated into baked goods. It also makes an excellent breading for chicken or fish, providing a simple yet effective way to enrich meals with essential nutrients.

As consumers become more health-conscious, the trend towards plant-based nutrition further fuels the market. Brewer yeast powder is widely used in health supplements, bakery products, and animal feed, showcasing its versatility.

Additionally, innovations in processing techniques and product formulations are expanding its application in various industries. Key players are focusing on sustainable sourcing and clean-label products to meet the rising consumer preference for transparency and quality. Overall, the brewer yeast powder market is poised for continued expansion, driven by health trends and innovative applications.

The surging popularity of veganism has emerged as a pivotal driver propelling the yeast extract market forward. With an increasing number of consumers adopting plant-based diets, there is a growing appetite for vegan-friendly alternatives that can faithfully replicate the savory tastes traditionally associated with animal-derived ingredients.

Yeast extract, renowned for its naturally occurring umami flavor, stands out as an exceptional substitute for meat-based flavors, particularly in the realm of vegan and vegetarian food products. This makes it an invaluable ingredient for food manufacturers looking to cater to the ever-expanding vegan market.

The capacity of yeast extract to enhance the palatability of vegan and vegetarian offerings ensures that consumers do not need to compromise on flavor when making dietary choices that align with their values.

The versatility of yeast extract allows it to meet the diverse needs and expectations of a significantly growing consumer base. As the global veganism movement continues to gain momentum, yeast extract is well-positioned to play a vital role in shaping the future of plant-based culinary experiences.

Contributions of yeast extract to enhancing taste, texture, and overall product quality drive the yeast extract market’s growth, revolutionize how we think about, and enjoy vegan and vegetarian food options.

Key Takeaways from the Market Study

  • The brewer yeast powder market valuation in 2022 stood at US$ 2,300 million.
  • The market in Japan accumulated a value share of 7.7% in 2022.
  • The market in India for brewer’s yeast is projected to develop at a CAGR of 13.8% in 2022.
  • The United Kingdom is estimated to expand at a CAGR of 4.2% by 2033.
  • Based on application, the feed segment is expected to dominate at a market share of 69% by 2033.
  • Based on type, the liquor dry yeast is likely to register a market share of 44% by 2033.
  • The brewer yeast powder market worth rose at a 2.4% CAGR between 2018 and 2022.

“The rising popularity of alcoholic beverages has increased the demand for brewer’s yeast and is considered one of the key drivers of the global brewer yeast powder market,” comments a Future Market Insights analyst.

Competitive Scenario

The brewer yeast powder industry consists of a consequential number of market players. Research and development are one of them that is mainly used for the introduction of environment-friendly product lines from the core aspect of these manufacturers. Other expansion strategies, including collaborations, mergers and acquisitions, and exploration of regulatory approvals, are also relied upon.

Key Companies Profiled

  • Inland Island Yeast Laboratories
  • Lesaffre
  • Associated British Foods plc
  • Lallemand Inc.
  • Angel Yeast Co. Ltd
  • AB Mauri Ltd
  • Laffort SA
  • Alltech Inc.
  • Oriental Yeast Co. Ltd
  • Omega Yeast Labs

Some key developments are-

  • Nutreco N.V. announced its investment in West Coast Salmon AS, a U.S.-based land-based salmon venture. The investment is part of West Coast Salmon’s initial round of equity financing, which will be used to establish a Recirculating Aquaculture System (RAS) Atlantic salmon farming facility in Nevada. This investment is a significant vote of confidence in the future of land-based salmon farming. It also demonstrates Nutreco’s commitment to sustainable aquaculture.
  • AB Mauri UK & Ireland has announced the appointment of four new professionals, a strategic move to extend the reach of its top-tier technical solutions across industries beyond the bakery sector. This expansion of technical solutions is part of AB Mauri UK & Ireland’s commitment to providing its customers with the best possible products and services. The company further believes that by expanding its reach, it can better serve the needs of its customers and help them grow their businesses.

More Valuable Insights Available

Future Market Insights offers an unbiased analysis of the global brewer yeast powder market providing historical data from 2018 to 2022 and forecast statistics from 2023 to 2033.

To understand opportunities in the global brewer yeast powder market is segmented based on type (alcohol dry yeast, liquor dry yeast, wine dry yeast, rice wine dry yeast, and beer dry yeast) and application (brewing, baking, feed, biological research, and medicine) across seven major regions (North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa).

Download the full report for in-depth insights. https://www.futuremarketinsights.com/reports/brewer-yeast-powder-market

Brewer Yeast Powder Market by Category

By Type

  • Alcohol Dry Yeast
  • Liquor Dry Yeast
  • Wine Dry Yeast
  • Rice Wine Dry Yeast
  • Beer Dry Yeast

By Application

  • Brewing
  • Baking
  • Feed
  • Biological Research
  • Medicine

By Region

  • North America
  • Latin America
  • Europe
  • The Middle East and Africa
  • East Asia
  • South Asia
  • Oceania

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

CBD Snack Market Poised for Growth, Projected at USD 2.5 Billion by 2032

Picture background

The CBD Snacks market contributed significantly to global food processing demand in 2022.

According to FMI analysis, growth in the CBD-infused snacks market may face challenges due to stringent regulations and the high cost of medical cannabis oil-infused food products.

Additionally, concerns over potential side effects, including allergies, headaches, and risks of substance misuse, are likely to hinder market expansion during the forecast period.

According to a recent report by Future Market Insights, a market research and competitive intelligence provider, sales of CBD snacks are estimated to reach a value of USD 2.5 Billion by 2032, surging at a 13.2% CAGR through the decade.

CBD demand is surging at an incredible rate, with growing applications in a diverse range of interconnected services and industries. CBD, which has been lauded by numerous experts for its extensive health benefits while avoiding the psychoactive effects of THC, is gaining widespread market acceptance around the world.

CBD markets are estimated to grow by 50% per year between 2021 and 22. Adoption rates are gradually increasing and will continue to rise as more people become aware of the issue. Each year, new medicinal and therapeutic uses are discovered as commercial manufacturing continues to produce an expanding variety of food products infused with CBD.

Key Takeaways from the Market Study

  • North America dominated the CBD snack market, accounting for more than 30% of revenue in 2021. The United States of America is positively contributing to market revenue.
  • China is making a positive contribution to market revenue. China is one of the world’s largest cultivators.
  • In 2021, the berry segment had a market share of more than 35%.
  • In 2020, the offline distribution channel had a market share of more than 70%.
  • From 2022 to 2032, the fastest CAGR is expected to be 17% for the online distribution channel segment.

“The CBD-infused snacks market is being driven by the growing popularity of CBD-infused snacks due to their therapeutic properties, as well as changes in consumer food habits,” says a lead analyst at Future Market Insights.

Competitive Landscape

Partnerships, associations, affiliations, mergers, and collaborations are among the strategies used by new entrants. With the help of these strategies, new players can gain crucial and much-needed market exposure that will assist them in understanding the dynamics of the global CBD snacks market.

Some of the key players in the CBD Snacks Market include ZBD, LivityFoods LLC, VELOBAR, Naturebox, Weller, Evo Hemp, CBD American Shaman, Dixie Brands Inc., Premium Jane, Pure Kana, and Just CBD.

Get More Valuable Insights

Future Market Insights, in its new offering, provides an unbiased analysis of CBD snacks presenting historical demand data (2017-2021) and forecast statistics for the period from 2022-2032.

Download the full report for in-depth insights. https://www.futuremarketinsights.com/reports/cbd-snacks-market

CBD Snacks Market by Category

By Type, the CBD Snacks Market is Segmented as:

  • Gummies
  • Bars
  • Cookies

By Distribution Channel, the CBD Snacks Market is Segmented as:

  • Hypermarkets/Supermarkets
  • Convenience Stores
  • Discount Stores
  • Pharmacy/Drug Stores
  • Food and Drink Specialty Stores
  • Independent Small Groceries
  • E Retailers

By Region, the CBD Snacks Market is Segmented as:

  • North America
  • Latin America
  • Europe
  • Middle east and Africa
  • East Asia
  • South Asia
  • Oceania

Frequently Asked Questions

  • At what rate will the CBD Snacks Market grow?
  • What is the expected value of the CBD Snacks Market by 2032?
  • What are the key factors driving the CBD Snacks Market?
  • Which region adds to the highest CBD Snacks Market Valuation?
  • What are the key strategies adopted by the major players of the CBD Snacks Market?
  • Who are the key players in the CBD Snacks Market?

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Edible Fungus Market Set to Reach USD 81.48 Billion by 2034 with a 4.5% CAGR

Edible Fungus

The anticipated market size of the global edible fungus market by 2034 will be USD 81.48 billion at a sluggish-to-moderate CAGR of 4.5%. The estimated market size after 2024 will be USD 52.24 billion.

The fundamental market driver for the subject market is the changing consumer preferences worldwide. Health consciousness is embraced by most of them, which emphasizes restructuring the diet. Mushroom provides a perfect option for nutrient-rich food. Consequently, its demand is rising, driving the subject market.

The growth of the food and beverage industry leverages the scope of innovation, allowing for different obsolete items to be included. Mushroom falls under the said category and has also gained popularity in the industry. Due to this, it drives the subject market.

Mushrooms have gained popularity as an alternative to meat. Consumers, being more inclined toward vegan and vegetarian diets, prefer mushrooms as a replacement for meat. Hence, this drives the market.

Key Takeaways from the Market Study

  • The Indian edible fungus market creates lucrative opportunities for many key players as it advances at the highest CAGR of 7.2%.
  • Germany leads the European market and advances at a CAGR of 4.2%.
  • The fresh edible fungi category is the largest segment, holding 67.3% of the market.
  • Button mushrooms are preferred more in the consumer market, justifying their 37.8% market share in the subject market.

“The establishment of an appropriate and well-structured distribution channel for the edible fungus market is a key market challenge,” says an FMI analyst.

Competitive Landscape

The fierce competition in the edible fungus market results from a large force exerted by a few key market players. The retail suppliers govern the competitive space. Various key market expansion modes, including mergers and acquisitions, product development, and market diversification, are used by businesses to govern the subject market.

The following are key market developments observed in the last few years in the given competitive landscape:-

  • In April 2022, Smithy Mushrooms was granted permission to expand its business by building an exotic mushroom farm at Bungalow Farm, Scarisbrick. This was a great opportunity for the business to develop in the edible fungus market.
  • In November 2023, Monterey Mushrooms, Inc. had to shut down Illinois and Florida farms. The organization claims to have faced many challenges in the hindsight of the pandemic, which resulted in the decision.

More Valuable Insights Available

Future Market Insights offers an unbiased edible fungus market analysis, providing historical data from 2019 to 2023 and forecast statistics from 2024 to 2034.

Product Type (Button Mushroom, Shiitake Mushroom, Oyster Mushroom, and Others), Form (Fresh, Processed, Dried, Frozen, and Canned), Nature (Organic and Conventional), and End Use (Food Processing Industries, Food Service Restaurants, Retail Outlets, Hypermarket/Supermarket, Convenience Stores, Departmental Stores, Wholesale Stores, Mass Grocery Retailers, Independent Retailers, Specialty Stores, and Online Retailers) segment of the subject market.

About the Food and Beverage Domain at Future Market Insights

Future Market Insights’ food and beverage team offers expert analysis, time-efficient research, and strategic recommendations to provide authentic insights and accurate results to help clients worldwide. With over 100+ reports and one million+ data points, the team has lucidly analyzed the industry in 50+ countries for over a decade. The team briefly analyses key trends, including competitive landscape, profit margin, and research development efforts.

Download the full report for in-depth insights. https://www.futuremarketinsights.com/reports/edible-fungus-market

Edible Fungus Market – Key Segments

By Product Type:

  • Button Mushroom
  • Shiitake Mushroom
  • Oyster Mushroom
  • Others

By Form:

  • Fresh
  • Processed
  • Dried
  • Frozen
  • Canned

By Nature:

  • Organic
  • Conventional

By End Use:

  • Food Processing Industries
  • Food Service Restaurants
  • Retail Outlets
  • Hypermarket/Supermarket
  • Convenience Stores
  • Departmental Stores
  • Wholesale Stores
  • Mass Grocery Retailers
  • Independent Retailers
  • Specialty Stores
  • Online Retailers

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • South Asia and Pacific
  • East Asia
  • The Middle East and Africa

About Future Market Insights (FMI):

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and market analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.

Contact Us:       

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Geriatric Population to accelerate the Spasticity Treatment Industry, reaching USD 28.4 Billion by the year 2033

The global spasticity treatment industry is worth USD 13.1 Billion as of now and is expected to reach USD 28.4 Billion by the year 2033 at a CAGR of 8.1% between 2023 and 2033.

Spasticity is turning out to be a common thing with growing frequency of neuro-musculoskeletal illnesses. This is evident from the fact that the year 2020 alone witnessed close to 2.5 Million multiple sclerosis patients worldwide. It needs to be noted that harm caused to brain/spinal cord do directly contribute to the traumatic brain injury and spinal cord injury respectively.

At the same time, the fact that there is a dearth of skilled specialists like neurologists, psychiatrists, occupational and physical therapists, rehabilitation nurses, language and speech pathologists, recreational therapists, social workers, and psychologists can’t be ignored. Factors like these could restrain the spasticity treatment industry in the near future.

Besides, the fact that geriatric population is increasing at an alarming rate can’t be ignored. The WHO states that the number of people aged 60 and above are expected to reach 1.4 Billion by the year 2050. It’s a known scenario that aged population is more prone to spasticity.

Future Market Insights has walked through these facets with future prospects in its latest market study entitled ‘Spasticity Treatment Market’. It has its dedicated team of analysts and consultants to deploy a bottom-up approach in its primary, secondary, and tertiary modes of research.

“With incidences of chronic ailments on the rise, the global spasticity treatment industry is expected to grow on an irreversible note in the forecast period”, says an analyst from Future Market Insights.

Key Takeaways from Spasticity Treatment Market:

  • Europe holds the largest market share on the back of Germany witnessing technological advancements. Virtual reality is being used for providing immersive therapy experiences for the ones suffering from spasticity.
  • The Asia-Pacific is expected to grow at the quickest rate in the spasticity treatment market with India and China leading from the front. These regions are increasingly investing in healthcare infrastructure.
  • North America is expected to witness steadiness in the spasticity treatment industry going forward with the US being persistent.

Heightened Market Interest: Our Complete Report Delivers Extensive Analysis and Trends!

Competitive Treatment:

  • Medtronic, August 2022, acquired Affera. The basic objective is that of providing the former access to the latter’s Prism-1 cardiac mapping and navigation platform; which shows compatibility with therapeutic catheters along with numerous competing technologies.
  • Allergen, in January 2020, did receive regulatory approval for using Botox for treating younger patients suffering from upper limb spasticity.
  • Ipsen Biopharmaceuticals, in July 2020, did announce that the US FDA had approved expanded usage of abobotulinumtoxinA (Dysport) to treat Spasticity in the pediatric patients.
  • The US FDA, in August 2020, completed approval of XEOMIN (incobotulinumtoxinA), a supplemental Biologics License Application.
  • Teva Pharmaceuticals, in August 2020, entered into collaboration with Alvotech for expanding sales all across the US.
  • Accent Therapeutics, in October 2021, inked an agreement with Ipsen for conducting research regarding spasticity drugs.

Key Companies Profiled:

  • Medtronic Plc
  • Piramal Enterprises Ltd.
  • AbbVie, Inc. (Allergan)
  • Ipsen Pharma
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline plc
  • Pfizer Inc.
  • Elite Pharmaceuticals Inc.
  • Orient Pharma
  • Acorda Therapeutics, Inc.
  • Sun Pharmaceutical Industries Ltd
  • Novartis AG (Alcon)
  • Teva Pharmaceutical Industries Ltd
  • Zydus Cadila Healthcare Ltd.
  • Beximco Pharmaceuticals Ltd
  • Merz Pharma
  • Thought Technology Ltd.
  • UltraCare PRO
  • Invacare Corporation
  • ATI Physical Therapy
  • P.T. Services Rehabilitation, Inc.
  • Banner Health

Key Segments Covered in Spasticity Treatment Industry Research:

By Diagnosis & Treatment Type:

  • Diagnosis
    • Inpatient
    • Outpatient
  • Treatment Type
    • Drug
      • Baclofen
      • Tizanidine
      • Dantrolene sodium
      • Diazepam
      • Clonazepam
      • Gabapentin
    • Physical Therapy
    • Botulinum injection
    • Surgery Treatment
    • Other Treatment
  • Devices
    • Reciprocal EMG-Triggered Stimulation
    • Transcutaneous Electrical Nerve Stimulation
    • Bracing and Cuff
    • Leg lifter
    • Cane and Crunches
    • Wheelchair
    • Others

By Indication:

  • Cerebral Palsy
  • Multiple Sclerosis
  • Amyotrophic Lateral Sclerosis
  • Hereditary Spastic Paraplegias
  • Periventricular Leukomalacia
  • Metabolic Diseases
  • Traumatic Brain Injury
  • Spinal Cord Injury
  • Stroke
  • Multiple System Atrophy
  • Stiff-Person Syndrome
  • Infectious Transvers Myelitis
  • Encephalopathy
  • Brain Tumor
  • Krabbe Disease
  • Johns Hopkins Disease

By Distribution Channel:

  • Hospitals Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Pharmacies

By Service Providers:

  • Hospitals
  • Ambulatory Surgical Centers
  • Home Care Settings
  • Specialty Clinics
  • Diagnostic Centers

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Pharmaceutical Sterility Testing Industry Set for Explosive Growth, Projected to Reach USD 3,815.6 Million by 2033

The global pharmaceutical sterility testing industry is on the brink of an extraordinary expansion, with forecasts predicting a meteoric rise from USD 1,250.7 million in 2023 to an impressive USD 3,815.6 million by 2033. This notable growth, driven by an 11.8% compound annual growth rate (CAGR), underscores the increasing demand for safe and effective medications amid a global surge in chronic diseases.

Sterility testing is a critical component in the pharmaceutical and biological industries, ensuring product safety and efficacy by identifying potential contamination risks throughout various production stages. This rigorous testing process is vital for protecting patients and maintaining high standards of healthcare.

This heightened demand underscores the industry’s commitment to rigorous safety standards, ensuring that all pharmaceutical products are free from viable contaminating microorganisms prior to their release into the market. The expansion of the sterility testing industry is indicative of a broader trend towards higher safety standards and quality assurance in the production of medical and pharmaceutical products.

As the pharmaceutical and healthcare sectors continue to evolve, the sterility testing industry is poised to play an even more pivotal role in the development and deployment of safe medical treatments, contributing to the overall growth and expansion of the global healthcare industry.

Potential Market Opportunity:

An increase in research and development expenditures in the biopharmaceutical industry contributed to the market’s expansion. For instance, in December 2021, the pharmaceutical industry’s annual research and development spending was 7.3 times higher than that of the aerospace and defense industries. Moreover, it was 6.5 times higher than that of the chemicals industry and 1.5 times higher than that of the software industry.

Key Takeaways:

  • By 2033, the pharmaceutical sterility testing market in the United Kingdom is likely to expand at a CAGR of 9.5%.
  • In 2022, the United States dominated the pharmaceutical sterility testing sector, with a share of 41.5%.
  • The pharmaceutical sterility testing industry was significantly expanding, with a size of USD 1,124.7 million in 2022.
  • By 2033, the pharmaceutical sterility testing industry in China is likely to expand, with a CAGR of 12.1%.
  • By 2033, Australia is projected to expand in the pharmaceutical sterility testing business, with an expected CAGR of 10.4%.
  • The market is expected to grow to USD 1,747. 75 million valuations by 2026, with rising automated techniques.
  • By 2033, India is projected to expand significantly in the pharmaceutical sterility testing sector, with a share of 12.8%.
  • Japan’s pharmaceutical sterility testing market share expanded significantly, with a 5.1% share in 2022.
  • In 2022, the outsourced segment dominated the market with a share of 54.1%. It is anticipated to control the market by 2033 in terms of services.
  • Based on product type, kits, and reagents dominated the market with a share of 39.7% in 2022.

Power Your Business Decisions with Insights from Get Full Report Now!

Key Players Operating in the Pharmaceutical Sterility Testing industry:

  • Merck KGaA
  • bioMerieux SA
  • Thermo Fisher Scientific Inc.
  • Charles River Laboratories International Inc.
  • Others

Recent Developments:

  • In June 2022

For its GMP batches, Berkshire Sterile Manufacturing opened a sterility testing isolator and conducted sterility testing. It provides sterile filling of injectable medications, the bulk of which are undergoing clinical trials or have little commercial need.

STEMart has started conducting thorough sterility and microbial tests for sterile, non-pyrogenic medical equipment.

  • Thermo Fisher Scientific announced plans to build two new sterile filling lines in Singapore in October 2020. To increase capacity for producing and developing vaccines and treatments in the APAC region.

Key Segments:

By Product:

  • Kits and Reagents
  • Instruments

By Application:

  • Sterile Drugs
  • Biologics and Therapeutics
  • Medical Devices

By Test Type:

  • Sterility Testing
    • Membrane Filtration
    • Direct Inoculation
  • Bacterial Endotoxin Testing
  • Rapid Micro Test
  • Container Closure Integrity Testing
  • Electrical Resistance
  • Bioburden Testing
  • ATP Bioluminescence
  • Fluorescent Labeling
  • Others

By Services:

  • In-House
  • Outsourced

By End Use:

  • Compounding Pharmacies
  • Medical Devices Companies
  • Pharmaceutical Companies

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • The Middle East & Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Nasal Allergy Treatment Industry to Reach USD 13.3 Billion by 2033, Driven by Innovation and Growing Awareness | Data by Future Market Insights, Inc.

According to Future Market Insights, the global nasal allergy treatment industry is poised for substantial growth, with its valuation expected to double from USD 6.6 billion in 2022 to USD 13.3 billion by 2033. The market is projected to exhibit a robust CAGR of 6.7% during the forecast period.

Nasal allergy, also known as allergic rhinitis (AR), is a prevalent non-infectious inflammatory condition of the nasal mucosa. It occurs following exposure to airborne allergens in individuals with atopic predisposition and is driven by IgE-mediated immune responses involving various immune cells and cytokines. Despite significant medical advancements, nasal allergies remain a persistent global health issue, affecting a substantial portion of the population.

Innovation and Development Fuel Market Growth:

The nasal allergy treatment industry has witnessed significant advancements in recent years, attributed to the growing interest of manufacturers and the concerted efforts of research and development teams. Companies are investing in cutting-edge therapeutic solutions to cater to unmet needs in allergy management. This surge of innovation includes improved pharmacological therapies, non-invasive treatments, and personalized medicine approaches designed to enhance patient outcomes.

Key Drivers of Market Expansion:

  1. Rising Allergy Awareness: Increased awareness campaigns about allergic conditions have encouraged early diagnosis and treatment, boosting market growth.
  2. Expanding Manufacturer Base: A growing number of pharmaceutical companies are entering the allergy treatment segment, fostering competition and innovation.
  3. New Therapies and Solutions: Research and development efforts have resulted in the launch of novel treatments that address the root causes of allergic rhinitis.

Challenges Persist:

Despite the positive market trajectory, challenges remain. A significant portion of the global population still endures nasal allergies, often due to delayed diagnosis, limited access to healthcare, or reluctance to seek treatment. Addressing these gaps will require continued innovation, enhanced healthcare access, and public education efforts.

Future Outlook:

With the market expected to reach USD 13.3 billion by 2033, stakeholders in the nasal allergy treatment sector are well-positioned to capitalize on this growth opportunity. Collaboration between manufacturers, healthcare providers, and policymakers will be instrumental in improving the quality of life for individuals suffering from nasal allergies.

Key Takeaways:

  • Allergic Rhinitis is the leading segment among other diseases, and holds around 65.8% market value share in 2022, owing to higher rates of identified cases.
  • Tablets/Capsules segment is set to lead in terms of the form of nasal allergy treatment with a projected market value share of around 33.6% by 2033, with respect to the physical and chemical attributes.
  • By prescription type, the widely adopted is OTC drugs as they are easily available without prescription and also the commonly prescribed drugs for allergy can be easily availed from drug stores. OTC by prescription type held a market share of 76.3% in the year 2022.
  • Multiple treatments are available but Antihistamines hold a significant share of 46.0% in the treatment segment as they can successfully treat wide range of allergic reaction symptoms.
  • By distribution channel, hospital pharmacies held a share of around 35.9% in 2022 due to easy accessibility of licensed and approved medications.
  • North American region dominated the global market with U.S. contributing 92.4% value share to North American market, owing to the prevalence of nasal allergies in the region.

“In light of the increasing demand for nasal allergy treatment and the increasing prevalence of allergies, the market for nasal allergy treatment is predicted to expand globally,” says an analyst at Future Market Insights (FMI).

Soaring Demand for Market Information: Uncover Detailed Trends and Insights in Our Report!

Market Competition:

The market for nasal allergy treatment represents a fragmented market. The market players are focused on developing and launching drugs and attaining approvals in order to improve treatment outcomes. Manufacturers are also looking ahead to acquisition and collaborations.

  • GlaxoSmithKline plc’s (GSK) Nucala (mepolizumab) received US Food and Drug Administration (FDA) on 29 July 2021. Nucala (mepolizumab) is a monoclonal antibody targeting interleukin-5 (IL-5). Patients with chronic rhinosinusitis with nasal polyps (CRSwNP) can be treated using this drug.
  • In April 2020, ALK Abello was pleased to share that Health Canada has approved once-daily ITULATEK, a sublingual tablet for the treatment of tree pollen allergy.

Key Players:

  • Merck KGaA
  • Johnson & Johnson
  • Allergopharma
  • Sanofi SA
  • McNeil Consumer Healthcare,
  • Genentech Inc.
  • GlaxoSmithKline PLC
  • Leti Pharma,
  • Alerpharma S.A
  • Allergan, Inc.
  • Meda Pharmaceuticals, Inc
  • Novartis International AG
  • Bausch Health Companies Inc.
  • Allergopharma
  • ALK Abello
  • Stallergenes Greer
  • Allergy Therapeutics
  • Aimmune Therapeutics
  • Biomay AG
  • HAL Allergy Group
  • Bayer
  • AstraZeneca

Key Market Segments Covered in the Nasal Allergy Treatment Industry Research:

By Disease Type:

  • Allergic Rhinitis
  • Seasonal Allergic Rhinitis
  • Perennial Allergic Rhinitis
  • Non-Allergic Rhinitis
  • Infectious Rhinitis

By Form:

  • Tablets/Capsules
  • Liquid
  • Creams & Lotions
  • Drops
  • Spray

By Prescription Type:

  • OTC
  • Prescription based

By Route of Administration:

  • Oral
  • Intranasal
  • Sublingual
  • Sub Cutaneous
  • Intravenous

By Treatment:

  • Antihistamines
  • Decongestants
  • Nasal Corticosteroids
  • Allergen Immunotherapy
  • Leukotriene Receptor Antagonists

By Distribution Channel:

  • Hospital Pharmacies
  • Supermarkets/Hypermarkets
  • Online Pharmacies
  • Retail Pharmacies
  • Speciality Clinics
  • Others

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East and Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Seasonal Allergy Industry Set to Surge to USD 2.58 Billion by 2033, Driven by Innovative Therapies and Increasing Prevalence: Future Market Insights

The global seasonal allergy industry is poised for significant growth, projected to expand from USD 1.22 billion in 2023 to USD 2.58 billion by 2033, at a robust compound annual growth rate (CAGR) of 7.8%, according to a recent report by Future Market Insights. Tablets and capsules, the leading form of treatment, commanded approximately 37.1% of the market share in 2022, underlining their continued dominance in this growing sector.

Seasonal allergies, often referred to as hay fever or allergic rhinitis, occur when the immune system overreacts to environmental triggers such as pollen. These allergies are most prevalent during spring, summer, and fall when specific plants release pollen into the air, causing widespread discomfort for millions of individuals globally.

The rising incidence of seasonal allergies has spurred innovation in the sector, with manufacturers increasingly recognizing the lucrative potential of the market. Investments in research and development are paving the way for novel therapies and advanced treatment options, expanding the arsenal available to healthcare providers. This surge in innovative approaches promises to cater to a broader spectrum of patients, offering better symptom management and improved quality of life.

Despite these advancements, a significant portion of the global population continues to grapple with the annual burden of seasonal allergies, highlighting the need for continued efforts to address unmet medical needs in this area.

As consumer awareness about seasonal allergies grows, and healthcare providers emphasize early diagnosis and effective management, the market is expected to witness sustained momentum in the coming decade.

Key Takeaways from Market Study:

  • Tablets/Capsules segment is set to lead in terms of the form of seasonal allergy with a projected market value share of around 33.6% by 2033, it is simple to swallow tablets and capsules because they don’t need to be prepared or measured.
  • OTC medications are the most popular prescription type because they are easily accessible without a prescription and because drug stores make it simple to obtain the often-prescribed allergy medications. In 2022, OTC by prescription held a 76.3% market share.
  • There are numerous treatments, but antihistamines dominate the therapy segment with a predominant share of 46.0%.
  • By distribution channel, hospital pharmacies held a share of around 35.9% in 2022. Hospital pharmacies have access to an extensive selection of specialty drugs that may not be offered by retail pharmacies.
  • North America held one-third value share of the global market in 2022, owing to the increasing prevalence of seasonal allergies in the region.

“With the increasing prevalence of seasonal allergies and the growing awareness about available treatment options, the market for seasonal allergy treatment is expected to witness significant growth in the coming years. Moreover, technological advancements in the development of novel therapies and the rising demand for personalized medicine are anticipated to shape the future trends in the seasonal allergy treatment market,” says an analyst of Future Market Insights.

Growing Need for Market Insights: Access Our Full Report for Thorough Analysis and Trends!

Market Competition:

Seasonal allergy is a market that is fragmented with multiple key players. The market participants are concentrated on developing, launching, and receiving approvals for pharmaceutical products in order to enhance treatment outcomes. Manufacturers are also anticipating mergers and partnerships.

  • ALK Abello and a major pharmaceutical company, Windgap Medical, announced a partnership in August 2019 to introduce a new generation of epinephrine auto-injector pens in the United States. This aided the business in increasing its market share in the United States
  • Anergis and Virometix agreed to a research partnership in July 2020 to examine synthetic virus-like particles for extremely quick allergy shots.

Key Companies Profiled:

  • Merck KGaA
  • Johnson & Johnson
  • Allergopharma
  • Sanofi SA
  • McNeil Consumer Healthcare,
  • Genentech Inc.
  • GlaxoSmithKline PLC
  • Leti Pharma,
  • Alerpharma S.A
  • Allergan, Inc.
  • Meda Pharmaceuticals, Inc
  • Novartis International AG
  • Bausch Health Companies Inc.

Key Market Segments Covered in the Seasonal Allergy Industry Research:

By Form:

  • Tablets/Capsules
  • Liquid
  • Creams & Lotions
  • Drops
  • Spray

By Prescription:

  • OTC
  • Prescription based

By Route of Administration:

  • Oral
  • Intranasal
  • Sublingual
  • Sub Cutaneous
  • Intravenous

By Treatment:

  • Antihistamines
  • Decongestants
  • Nasal Corticosteroids
  • Allergen Immunotherapy
  • Leukotriene Receptor Antagonists

By Distribution Channel:

  • Hospital Pharmacies
  • Supermarkets/Hypermarkets
  • Online Pharmacies
  • Retail Pharmacies
  • Speciality Clinics
  • Others

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East and Africa (MEA)


About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube